Stephanie A Massaro, MD, MPH

Clinician in Pediatrics (Hematology / Oncology)

Clinical Interests

  • Hematologic Diseases
  • Leukemia

Patient Care

Accepts new patients? Yes
Patient Type: Adolescent; Child
Referrals: From patients or physicians

Patient Care Organizations

Pediatrics: Hematology & Oncology

Pediatric Hematology & Oncology Program

Yale Medicine

Board Certifications

  • Pediatrics AB of Pediatrics (2007)

  • Pediatric Hematology-Oncology AB of Pediatrics (2013)

Clinical Trials

Conditions Study Title
Hodgkin's Lymphoma, Kaposi's sarcoma, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Mycosis Fungoides, Non-Hodgkin's Lymphoma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Pediatrics, Anus, Bladder, Bones and Joints, Brain and Nervous System, Breast - Female, Breast - Male, Cervix Uteri, Colon, Corpus Uteri, Esophagus, Eye and Orbit A Phase I/II Study of Pembrolizumab (MK-3475) in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma (KEYNOTE-051)
Myeloid and Monocytic Leukemia, Pediatrics Gemtuzumab Ozogamicin (Mylotarg (Registered)) Expanded Access Protocol For Treatment Of Patients In The United States With Relapsed/Refractory Acute Myelogenous Leukemia Who May Benefit From Treatment And Have No Access To Other Comparable/Alternative Therapy
Brain and Nervous System, Pediatrics A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Bones and Joints, Pediatrics A Phase 2 Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038) in Combination With Sargramostim (GM-CSF) in Patients With Recurrent Osteosarcoma
Leukemia, other A Phase I, Open-label, Adaptive Dose-escalation, Multicenter Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Anti-tumor Activity of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)
Bones and Joints, Brain and Nervous System, Eye and Orbit, Hodgkin's Lymphoma, Kidney, Leukemia, other, Liver, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Small Intestine, Soft Tissue, Pediatrics The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Leukemia, not otherwise specified, Pediatrics Risk-Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Brain and Nervous System, Phase I, Pediatrics A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma
Non-Hodgkin's Lymphoma, Pediatrics A Randomized Phase II Trial of Brentuximab Vedotin, or Crizotinib in Combination With Chemotherapy for Newly Diagnosed Patients With Anaplastic Large Cell Lymphoma (ALCL)
Hodgkin's Lymphoma, Pediatrics A Randomized Phase III Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
Soft Tissue, Pediatrics Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Brain and Nervous System, Pediatrics Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Lymphoid Leukemia, Pediatrics Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
Other Respiratory and Intrathoracic Organs, Pediatrics Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment (HEART)
Myeloid and Monocytic Leukemia, Pediatrics Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Lymphoid Leukemia, Pediatrics Neuropsychological and Behavioral Testing in Younger Patients With Cancer
Lymphoid Leukemia, Pediatrics Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Brain and Nervous System, Pediatrics Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
Liver, Pediatrics Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Bones and Joints, Brain and Nervous System, Hodgkin's Lymphoma, Kidney, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Male Genital, Soft Tissue, Pediatrics Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group

Edit this profile

Contact Info

Stephanie A Massaro, MD, MPH
Patient Care Location
Yale Pediatric Hematology/OncologySmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste 7th floor

New Haven, CT 06511
View on map...
Lab Location
Amistad Street Building
10 Amistad Street, Ste 214

New Haven, CT 06519
View on map...
Mailing Address
PO Box 208064
New Haven, CT 06520-8064

Curriculum Vitae

The Krause Laboratory